Related Experiment Video
Updated: Nov 4, 2025
07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
6.0K
Molecular Markers that Matter in Salivary Malignancy
Katherine C Wai1, Hyunseok Kang2, Patrick K Ha1
1Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco 550 16th Street, 6th floor, UCSF Box 3213, San Francisco, CA 94158, USA.
Otolaryngologic Clinics of North America
|May 24, 2021
Summary
Recurrent salivary gland cancer often requires new treatments as standard chemotherapy lacks lasting effects. This review focuses on molecular markers investigated in clinical trials for salivary gland cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Recurrent and metastatic salivary gland cancer presents a significant clinical challenge.
- Standard chemotherapy regimens offer limited durable benefits for advanced salivary gland cancers.
Purpose of the Study:
- To review and highlight molecular markers targeted in clinical trials for salivary gland cancers.
- To provide an overview of emerging therapeutic strategies based on molecular profiling.
Main Methods:
- Literature review of clinical trials targeting molecular markers in salivary gland cancers.
- Analysis of identified molecular targets across various histologic subtypes.
Main Results:
- Several molecular markers have shown promise in different salivary cancer subtypes.
- Targeted therapies are being investigated to overcome limitations of traditional chemotherapy.
Conclusions:
- Molecular markers represent a key area for developing novel treatments for salivary gland cancers.
- Targeted clinical trials are crucial for advancing the management of recurrent/metastatic disease.
